BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02038647-completion@plaintrial.com
DTSTAMP:20261027T224745Z
DTSTART;VALUE=DATE:20170710
SUMMARY:Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel
  Versus Placebo in Combination With Paclitaxel as Second Line Therapy for 
 Small Cell Lung Cancer (SCLC) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02038647
URL:https://plaintrial.com/trial/NCT02038647
END:VEVENT
END:VCALENDAR